Menu
Back to Journals » Vascular Health and Risk Management » Volume 8
Review
Patient considerations and clinical impact of cholesteryl ester transfer protein inhibitors in the management of dyslipidemia: focus on anacetrapib
| Total article views | Abstract views | HTML views | PDF downloads | Totals | |
|---|---|---|---|---|---|
| 9,773 | Dovepress* | 7,726 | 564+ | 1,783 | 8,290 |
| PubMed Central* | 7 | 1,476 | 606 | 1,483 | |
| Totals | 7,733 | 2,040 | 2,389 | 9,773 | |
|
*Since 23 August 2012 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 |
View citations on PubMed Central and Google Scholar